Health in North Korea 971 indicators covering health for North Korea. IndicatorLatest Year10-yr change Rank ENAP target met stillbirth rate 6.67 2030 down 16.2% 104th Stillbirth rate high-income country 2.8 2030 down 60.2% 1st Stillbirths remain constant projection 2,486 2030 down 11.8% 67th Stillbirth maintained projection 2,020 2030 down 26.1% 68th Stillbirth ENAP 2030 target met projection 2,020 2030 down 26.1% 68th Stillbirth high-income country average rate matched projection 844 2030 down 65.0% 70th Stillbirth rate current trends 6.67 2030 down 16.2% 104th Life satisfaction vs. life expectancy 73.64 years 2023 up 2.5% 133rd Estimate of current cigarette smoking prevalence 12.2% 2030 down 20.8% 87th Estimate of current cigarette smoking prevalence (%) 11.6% 2030 down 23.2% 90th Tuberculosis patients who tested positive for HIV 0 patients 2021 — 160th Number of children aged 6-59 months with anaemia 551.19 2019 down 3.5% 66th Prevalence of anaemia in children aged 6-59 months 31.6% 2019 down 4.0% 82nd Number of deaths attributed to non-communicable diseases, by type of 36,943 2019 up 23.1% 36th Hepatitis B surface antigen (HBsAg) prevalence 0.4% 2024 down 20.0% 62nd Mortality caused by road traffic injury 24.2 per 100,000 population 2019 up 3.4% 49th Mortality caused by road traffic injury, female 11.9 per 100,000 female population 2019 down 3.3% 56th Mortality caused by road traffic injury, male 37 per 100,000 male population 2019 up 5.7% 46th Mean hemoglobin level of children aged 6-59 months 115 2019 unchanged 110th Neonatal mortality rate - Remains constant 8.94 2030 unchanged 93rd Neonatal mortality rate - Current trends maintained 7.6 2030 down 12.7% 93rd Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 62.0% 1st Neonatal mortality rate - SDG target met 7.6 2030 down 12.7% 93rd Under 5 mortality rate - Remains constant 16.67 2030 unchanged 89th Under 5 mortality rate - Current trends maintained 14.13 2030 down 12.9% 88th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 62.8% 1st Under 5 mortality rate - SDG target met 14.13 2030 down 12.9% 88th Mortality rate age 10-19 - Remains constant 5.57 2030 down 0.9% 90th Mortality rate age 10-19 - Current trends maintained 5.09 2030 down 8.0% 89th Mortality rate age 10-19 - High-income country average rate matched 3.54 2030 down 29.0% 87th Neonatal deaths - Remains constant 2,691 2030 down 10.2% 68th Neonatal deaths - Current trends maintained 2,286 2030 down 21.6% 68th Neonatal deaths - SDG target met 2,286 2030 down 21.6% 65th Under-five deaths - Remains constant 5,115 2030 down 9.4% 68th Under-five deaths - Current trends maintained 4,337 2030 down 21.0% 68th Under-five deaths - SDG target met 4,337 2030 down 21.0% 66th Deaths age 10 to 19 - Remains constant 1,861 2030 up 1.1% 67th Deaths age 10 to 19 - Current trends maintained 1,683 2030 down 7.0% 66th Share of one-year-olds who received the inactivated polio vaccine 50.0% 2024 down 38.3% 191st Tuberculosis patients living with HIV receiving antiretroviral therapy 0 patients 2021 — 141st Treatment success rate for patients treated for MDR-TB 80.0% 2022 down 7.0% 50th New leprosy case detection rate per 1 000 000 population 0 2024 — 124th Prevalence of wasting, weight for height 2.5% 2017 down 51.9% 72nd Weight-for-height <-2 SD 2.5 2017 down 51.9% 71st Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 0.0% 2025 — 167th International Health Regulations core capacity scores, SPAR version 90 2025 — 14th Prevalence of underweight, weight for age 9.3% 2017 down 50.5% 53rd Leprosy registered prevalence rate per 1 000 000 population 0 2024 — 121st Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 0 2024 — 121st New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th Number of one-year-olds who have not received the inactivated polio vaccine 3,420 one-year-olds 2023 down 94.6% 119th Contraceptive prevalence, any method 70.2% 2017 up 1.6% 20th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of female leprosy new cases 0 2024 — 102nd Estimated number of malaria deaths 0 2024 — 66th Estimated number of malaria cases 5,233 2024 down 50.3% 63rd Contraceptive prevalence, any modern method 68.8% 2017 up 17.6% 14th National smoking ban: NUMBER OF PLACES SMOKE-FREE 7 2022 up 133.3% 74th Number of prevalent tuberculosis cases 140,000 2014 up 27.3% 17th ← Previous Page 15 of 17 Next →